Clopidogrel an alternative to ticlopidine in coronary stenting

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1223, 2000-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel vs ticlopidine: tolerability after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cilostazol outperforms ticlopidine after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Clopidogrel Resistance: Implications for Coronary Stenting

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1261-1269

Bentham Science Publishers

Access to resources Recommend Favorite

Clopidogrel + eptifibatide CLEARs PLATELETS after coronary stenting

By  

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Clopidogrel: The Future Choice for Preventing Platelet Activation During Coronary Stenting?

By Gurbel P.A.   O'connor C.M.   Cummings C.C.   Serebruany V.L.  

Pharmacological Research, Vol. 40, Iss. 2, 1999-08 ,pp. : 107-111

Academic Press

Access to resources Recommend Favorite